Evidence map›Paper›PMID 33187221›Full record

ArticleCancers2020

Increased PARP Activity and DNA Damage in NSCLC Patients: The Influence of COPD.

Jun Tang, Víctor Curull, Xuejie Wang, Coral Ampurdanés, Xavier Duran, Lara Pijuan, Alberto Rodríguez-Fuster, Rafael Aguiló, José Yélamos, Esther Barreiro

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jun TangPulmonology Department, Lung Cancer and Muscle Research Group, Hospital del Mar-IMIM, Parc de Salut Mar, Health and Experimental Sciences Department (CEXS), Universitat Pompeu Fabra (UPF), Medical School, Universitat Autònoma de Barcelona, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.
Víctor CurullPulmonology Department, Lung Cancer and Muscle Research Group, Hospital del Mar-IMIM, Parc de Salut Mar, Health and Experimental Sciences Department (CEXS), Universitat Pompeu Fabra (UPF), Medical School, Universitat Autònoma de Barcelona, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.
Xuejie WangPulmonology Department, Lung Cancer and Muscle Research Group, Hospital del Mar-IMIM, Parc de Salut Mar, Health and Experimental Sciences Department (CEXS), Universitat Pompeu Fabra (UPF), Medical School, Universitat Autònoma de Barcelona, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.
Coral AmpurdanésCancer Research Program, Hospital del Mar Medical Research Institute (IMIM)-Hospital del Mar, 08003 Barcelona, Spain.
Xavier DuranScientific, Statistics and Technical Department, Hospital del Mar-IMIM, Parc de Salut Mar, 08003 Barcelona, Spain.
Lara PijuanPathology Department, Hospital del Mar-IMIM, Parc de Salut Mar, 08003 Barcelona, Spain.
Alberto Rodríguez-FusterThoracic Surgery Department, Hospital del Mar-IMIM, Parc de Salut Mar, 08003 Barcelona, Spain.
Rafael AguilóThoracic Surgery Department, Hospital del Mar-IMIM, Parc de Salut Mar, 08003 Barcelona, Spain.
José YélamosCancer Research Program, Hospital del Mar Medical Research Institute (IMIM)-Hospital del Mar, 08003 Barcelona, Spain.ORCID 0000-0003-1195-1496
Esther BarreiroPulmonology Department, Lung Cancer and Muscle Research Group, Hospital del Mar-IMIM, Parc de Salut Mar, Health and Experimental Sciences Department (CEXS), Universitat Pompeu Fabra (UPF), Medical School, Universitat Autònoma de Barcelona, Parc de Recerca Biomèdica de Barcelona (PRBB), 08003 Barcelona, Spain.
Parc de Salut · ESUniversitat Autònoma de Barcelona · ESHospital Del Mar · ES

Funding

Instituto de Salud Carlos III CIBERES 2019Instituto de Salud Carlos III FIS 18/00075SEPAR 2018SEPAR 2020
6 · The paper itself

Abstract

(1)

Indexed as

COPDDNA damagelung cancerPARP-1 and PARP-2 expressionPARP activity

Identifiers

PMID33187221
PMCPMC7697659
OpenAlexW3104632586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.